What Challenges Exist in the Study of Phagocytosis and Nanotechnology?
Several challenges exist in the study of the interplay between phagocytosis and nanotechnology:
In Vivo Complexity: The in vivo environment is highly complex, and results obtained in vitro may not always translate directly. Biocompatibility: Ensuring that nanoparticles are biocompatible and do not elicit an adverse immune response remains a significant challenge. Clearance and Toxicity: Understanding how nanoparticles are cleared from the body and their potential long-term toxicity is crucial for safe application.
